New randomized, double-blind, placebo-controlled study adds to Perelel's growing body of clinical research designed to advance science-baked solutions in women's health.

LOS ANGELES, Aug. 20, 2026 /PRNewswire/ -- Perelel, the OB/GYN founded women's health brand built on clinical expertise and known for revolutionizing women's health through targeted, research-backed nutrition, today announced new clinical results from a randomized, double-blind, placebo-controlled study of its Triple-Support Protein, a patent-pending three-in-one formula combining plant-based protein, creatine monohydrate and low-FODMAP prebiotic fiber.

Originally published on the BLOX Digital Content Exchange.

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.